Haemonetics (HAE) Interest Expenses (2009 - 2026)

Haemonetics' Interest Expenses history runs 18 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• On a quarterly basis, Interest Expenses rose 7471.21% year-over-year to $4.9 million in Q1 2026; TTM through Mar 2026 was $22.8 million, a 22.77% decrease from a year earlier, with the FY2026 full-year figure at $60.0 million, up 35.39% from the prior year.
• Interest Expenses fell to $4.9 million in Q1 2026 per HAE's latest filing, from $43.5 million in the prior quarter.
• Across five years, Interest Expenses topped out at $45.3 million in Q2 2025 and bottomed at -$66000.0 in Q1 2025.
• The 5-year median for Interest Expenses is $14.5 million (2023), against an average of $21.5 million.
• Across the five-year window, Interest Expenses surged 8731.2% in 2024 and slumped 100.38% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $8.5 million in 2022, then soared by 286.34% to $32.8 million in 2023, then surged by 36.93% to $45.0 million in 2024, then slipped by 3.21% to $43.5 million in 2025, then plunged by 88.82% to $4.9 million in 2026.
• Per Business Quant, the three latest HAE Interest Expenses figures stand at $4.9 million (Q1 2026), $43.5 million (Q4 2025), and $43.9 million (Q3 2025).